Budgetmotion om ökat anslag för läkemedelsersättningar för diabetes (20 000 000 euro)

This budget motion proposes an increase of 20 million euros in funding for pharmaceutical reimbursements specifically for diabetes medication. The aim is to make essential diabetes treatments more affordable for patients. This measure would primarily affect individuals with diabetes who rely on prescription medications. It could also impact the national health insurance budget and pharmaceutical companies.